News
Convalescent plasma: ‘Flavor of the month’ or valid COVID-19 treatment?
May 26, 2020
“The special attraction of this modality of treatment is that, unlike vaccines or newly developed drugs, it could, in principle, be made available very rapidly.”
![1]()
News
Patient-focused precautions, testing help blunt pandemic effects on heme-onc unit
May 26, 2020
Multiple factors helped keep the anticipated COVID-19 surge manageable at the hematologic oncology service of Levine Cancer Institute.
![1]()
News
Inflammation, thrombosis biomarkers tied to COVID-19 deaths
May 20, 2020
“Of particular interest is the finding that over three quarters of critically ill patients required a ventilator and almost one third required renal dialysis support.”
![1]()
News
DOACs linked to lower fracture risk versus warfarin in AFib patients
May 20, 2020
The results suggest women may particularly benefit from DOAC use.
![1]()
News
COVID-19–associated coagulopathy
May 7, 2020
Early recognition and anticoagulation is imperative to improve clinical outcomes in COVID-19–associated coagulopathies.
News
COVID-19 pulmonary severity ascribed to coagulation differences
May 6, 2020
Higher mortality risk among whites with severe COVID-19 infections may be linked to higher propensity for thromboembolism than Chinese patients.
News
COVID-19 death rate was twice as high in cancer patients in NYC study
May 5, 2020
The overall case fatality rate was 28% for cancer patients with COVID-19 and 14% for noncancer COVID-19 patients.
News
Excess cancer deaths predicted as care is disrupted by COVID-19
May 1, 2020
Researchers are predicting that, 1 year from now, there will be 33,890 excess deaths among cancer patients in the United States over the age of 40.
News
EHA and TIF explore how COVID-19 is affecting thalassemia and SCD patients
April 20, 2020
Thalassemia patients appeared to fare relatively well after COVID-19 diagnosis in anecdotal series reports from Europe.
News
Can convalescent plasma treat COVID-19 patients?
April 17, 2020
How COVID-19 patients can receive convalescent plasma, who is eligible to donate, and early results of treatment.
